龍津藥業(002750.SZ):共同投設的藥品銷售公司已領取營業執照
格隆匯 9 月 17日丨龍津藥業(002750.SZ)公佈,公司於2020年9月1日召開第四屆董事會第十九次會議,審議通過了《關於向全資子公司增資及其對外投資的議案》,公司董事會同意全資子公司雲南龍津梵天生物科技有限責任公司(“龍津梵天”)與合作方雲南愛創投資有限公司(“愛創投資”)、龍津梵天的控股子公司雲南龍津睿達醫藥技術合夥企業(有限合夥)(“龍津睿達”)簽署《合資成立公司合作協議》、《合作協議》,共同對外投資設立一家藥品銷售公司。
龍津梵天與愛創投資、龍津睿達共同投資設立的藥品銷售公司已辦理完成工商註冊登記並領取《營業執照》,該公司名稱為雲南龍津藥業銷售有限公司,經營範圍:藥品、塑料製品、紙製品、預包裝食品、橡膠製品、玻璃製品、農副產品、消毒產品(不含危險化學品)、化粧品、健身器械、衞生用品、日用百貨、保健食品、I類、II類醫療器械的銷售;III類醫療器械的批發;健康諮詢;市場分析調查服務;企業形象設計及營銷策劃;數據處理和存儲支持服務;計算機軟硬件的研發技術諮詢、技術服務;生物技術的研究、開發、技術諮詢。(依法須經批准的項目、經相關部門批准後方可開展經營活動)
雲南龍津藥業銷售有限公司完成工商註冊登記後,相關投資人將盡快完成認繳資金繳納並開展經營活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.